{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:49Z","timestamp":1786119109786,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"DOI":"10.1097\/qai.0b013e31818ffdff","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T03:40:27Z","timestamp":1229398827000},"page":"9-18","source":"Crossref","is-referenced-by-count":17,"title":["Envelope Coreceptor Tropism, Drug Resistance, and Viral Evolution Among Subtype C HIV-1-Infected Individuals Receiving Nonsuppressive Antiretroviral Therapy"],"prefix":"10.1097","volume":"50","author":[{"given":"Seble","family":"Kassaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"McColgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Zijenah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Katzenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210131","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1128\/JVI.79.3.1734-1742.2005","article-title":"Semen-specific genetic characteristics of human immunodeficiency virus type 1 env.","volume":"79","author":"Pillai","year":"2005","journal-title":"J Virol"},{"key":"R2-2-20210131","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00002030-199709000-00002","article-title":"Biological correlates of HIV-1 heterosexual transmission.","volume":"11","author":"Fiore","year":"1997","journal-title":"AIDS"},{"key":"R3-2-20210131","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/viro.1997.8996","article-title":"Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles.","volume":"241","author":"Shankarappa","year":"1998","journal-title":"Virology"},{"key":"R4-2-20210131","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jac\/dkm012","article-title":"Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.","volume":"59","author":"de Mendoza","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R5-2-20210131","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1128\/JVI.68.7.4400-4408.1994","article-title":"Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.","volume":"68","author":"Connor","year":"1994","journal-title":"J Virol"},{"key":"R6-2-20210131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.virol.2005.11.045","article-title":"Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.","volume":"347","author":"Arien","year":"2006","journal-title":"Virology"},{"key":"R7-2-20210131","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/infdis\/173.2.349","article-title":"Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection.","volume":"173","author":"Koot","year":"1996","journal-title":"J Infect Dis"},{"key":"R8-2-20210131","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/428096","article-title":"Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection.","volume":"191","author":"Moyle","year":"2005","journal-title":"J Infect Dis"},{"key":"R9-2-20210131","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/0003-4819-118-9-199305010-00004","article-title":"Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.","volume":"118","author":"Koot","year":"1993","journal-title":"Ann Intern Med"},{"key":"R10-2-20210131","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(05)71139-9","article-title":"Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report.","volume":"365","author":"Markowitz","year":"2005","journal-title":"Lancet"},{"key":"R11-2-20210131","doi-asserted-by":"crossref","first-page":"13376","DOI":"10.1128\/JVI.77.24.13376-13388.2003","article-title":"Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.","volume":"77","author":"Jensen","year":"2003","journal-title":"J Virol"},{"key":"R12-2-20210131","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/JCM.33.4.906-911.1995","article-title":"Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR.","volume":"33","author":"Fouchier","year":"1995","journal-title":"J Clin Microbiol"},{"key":"R13-2-20210131","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1128\/JVI.66.5.3183-3187.1992","article-title":"Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.","volume":"66","author":"Fouchier","year":"1992","journal-title":"J Virol"},{"key":"R14-2-20210131","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1128\/JVI.78.6.2841-2852.2004","article-title":"Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.","volume":"78","author":"Pollakis","year":"2004","journal-title":"J Virol"},{"key":"R15-2-20210131","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/aid.2006.0130","article-title":"Structural basis for coreceptor selectivity by the HIV type 1 V3 loop.","volume":"23","author":"Cardozo","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R16-2-20210131","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.qai.0000173460.75322.93","article-title":"Enhanced replicative capacity and pathogenicity of HIV-1 isolated from individuals infected with drug-resistant virus and declining CD4+ T-cell counts.","volume":"40","author":"Solomon","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-2-20210131","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.qai.0000152835.17747.47","article-title":"R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy.","volume":"38","author":"Delobel","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R18-2-20210131","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/507312","article-title":"Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia.","volume":"194","author":"Hunt","year":"2006","journal-title":"J Infect Dis"},{"key":"R19-2-20210131","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1089\/aid.2006.22.1142","article-title":"Inverse relationship between viral load and genotypic resistance mutations in Korean patients with primary HIV type 1 infections.","volume":"22","author":"Chin","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R20-2-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.20316","article-title":"Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.","volume":"76","author":"de Mendoza","year":"2005","journal-title":"J Med Virol"},{"key":"R21-2-20210131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/aid.2005.21.13","article-title":"Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)\/viral load discordance.","volume":"21","author":"Kaplan","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R22-2-20210131","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.aids.0000199825.34241.49","article-title":"Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.","volume":"20","author":"Bangsberg","year":"2006","journal-title":"AIDS"},{"key":"R23-2-20210131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00042560-199902010-00002","article-title":"Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses.","volume":"20","author":"Peeters","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R24-2-20210131","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/00002030-199907300-00006","article-title":"HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS.","volume":"13","author":"Abebe","year":"1999","journal-title":"AIDS"},{"key":"R25-2-20210131","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1128\/JVI.77.13.7682-7688.2003","article-title":"High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment.","volume":"77","author":"Johnston","year":"2003","journal-title":"J Virol"},{"key":"R26-2-20210131","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/JVI.80.10.4698-4704.2006","article-title":"A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.","volume":"80","author":"Jensen","year":"2006","journal-title":"J Virol"},{"key":"R27-2-20210131","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/bioinformatics\/14.9.817","article-title":"MODELTEST: testing the model of DNA substitution.","volume":"14","author":"Posada","year":"1998","journal-title":"Bioinformatics"},{"key":"R28-2-20210131","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1089\/088922202320935483","article-title":"HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.","volume":"18","author":"Kantor","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R29-2-20210131","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/508655","article-title":"Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen.","volume":"43","author":"Hatano","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R30-2-20210131","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199610103351502","article-title":"The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.","volume":"335","author":"Katzenstein","year":"1996","journal-title":"N Engl J Med"},{"key":"R31-2-20210131","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1086\/345870","article-title":"Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy.","volume":"187","author":"Tierney","year":"2003","journal-title":"J Infect Dis"},{"key":"R32-2-20210131","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/01.aids.0000131358.29586.6b","article-title":"Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy.","volume":"18","author":"Kantor","year":"2004","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e31818ffdff","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:27:21Z","timestamp":1786037241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200901010-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31818ffdff","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1,1]]}}}